These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5150790)

  • 1. Late results following rifampicin therapy and tolerance of rifampicin given on a long-term basis.
    Flemming J; Virchow C
    Respiration; 1971; 28():Suppl:107-15. PubMed ID: 5150790
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
    Macquet V; Lafitte P; Rogeaux Y
    Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
    Verbist L; Rollier F
    Respiration; 1971; 28():Suppl:17-28. PubMed ID: 5150793
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 6. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
    Salinger PL; Dormer BA
    S Afr Med J; 1972 Mar; 46(13):354-8. PubMed ID: 5074542
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
    Gulati K; Ray A; Vijayan VK
    Indian J Exp Biol; 2010 Mar; 48(3):318-22. PubMed ID: 21046988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin and thrombocytopenia.
    Leggat PO
    Lancet; 1971 Jul; 2(7715):103-4. PubMed ID: 4103969
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidaemia as a complication of rifampicin treatment.
    Khogali AM; Chazan BI; Metcalf VJ; Ramsay JH
    Tubercle; 1974 Sep; 55(3):231-3. PubMed ID: 4470842
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin hepatitis. A clinical and histological study.
    Scheuer PJ; Summerfield JA; Lal S; Sherlock S
    Lancet; 1974 Mar; 1(7855):421-5. PubMed ID: 4131429
    [No Abstract]   [Full Text] [Related]  

  • 13. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 14. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatoxic side-effects of rifampicin. A comparative clinical study].
    Kuntz HD; Rausch V
    Med Welt; 1977 Nov; 28(47):1940-2. PubMed ID: 342868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rimactan (rifampicin) and anticoagulant therapy].
    Michot F; Bürgi M; Büttner J
    Schweiz Med Wochenschr; 1970 Mar; 100(13):583-4. PubMed ID: 5420855
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver tolerance of rifampicin].
    Ewert EG
    Prax Pneumol; 1973 Apr; 27(4):235-40. PubMed ID: 4698442
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster B; Murray FJ; Ferebee S
    Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.